Skip to main content
ALB logo

Albemarle Corp

Exchange: NYSESector: Basic MaterialsIndustry: Specialty Chemicals

Albemarle Corporation is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers.

Did you know?

Price sits at 88% of its 52-week range.

Current Price

$178.09

-0.21%
Profile
Valuation (TTM)
Market Cap$20.96B
P/E-30.94
EV$21.30B
P/B2.20
Shares Out117.70M
P/Sales4.08
Revenue$5.14B
EV/EBITDA43.97

Albemarle Corp (ALB) Financial Statements

GoodMoat Analysis

Based on data as of March 26, 2026

Albemarle's financial health presents a mixed picture for a value investor. While revenue growth is positive, the company is currently unprofitable with negative margins and returns, which is a significant concern. The balance sheet appears reasonably leveraged, but the quality indicators are currently weak.

Read full analysis
Analyzing Albemarle through the GoodMoat Quality Indicators reveals several unfavourable signals. The company is not GAAP profitable, with a negative EPS of -$5.76 and an operating margin of -7.1%. This fails the framework's profitability check. The negative ROE of -5.4% also falls far short of the high-quality threshold of >15-20% for Return on Invested Capital (ROIC). While a 15.9% YoY revenue growth rate is solid, it is not sufficient to offset the current lack of profitability. The Free Cash Flow yield of 3.4% suggests some cash generation, but the framework looks for a growing FCF margin >10-15%, which is not confirmed by the provided data. On a more positive note, the balance sheet shows moderate leverage with a Debt/Equity ratio of 0.33, which is below the framework's cautionary threshold of 1.0x Debt/EBITDA, though EBITDA data is not provided to confirm this. The Growth Assessment shows a durable revenue growth trajectory, but the key issue is the lack of investment efficiency and operating leverage, as this growth is not translating into profits or high returns at present. For a value investor focused on financial strength, the current profile is unfavourable due to the margin compression and lack of profitability, despite the reasonable debt level.

ALB Financial Data

EBITDA$512.58M
Revenue (TTM)$5.14B
Gross Profit (TTM)$668.72M
Gross Margin
Operating Margin-7.14%
ROE-5.36%
ROA-3.12%
Debt/Equity0.33
Current Ratio2.23
FCF$725.28M
FCF Yield3.46%
Piotroski F-Score
Rev/Share (TTM)$43.69
50-Day MA$172.27
200-Day MA$117.04
Shares Outstanding0.12B

ALB Computed Insights

FCF$725.28M
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

ALB Financial Statements & Data

Albemarle Corp (ALB) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Albemarle Corp's financial performance and position as a Basic Materials company.

Trailing twelve-month (TTM) revenue is $5.14B. Gross profit (TTM) is $668.72M. EBITDA is $512.58M. Earnings per share (EPS) is $-5.76. The P/E ratio is -30.94. Market capitalization is $20.96B.

Free cash flow (FCF) is $725.28M. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Albemarle Corp's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.